Antiphospholipid syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:


The most common risk factors of antiphospholipid syndrome risk factors are history of autoimmune diseases like SLE, sjogren's syndrome, infections- cytomegalovirus, human immunodeficiency virus, parvovirus B-19, hepatitis C virus, lyme's disease, syphilis, E.coli, leptospirosis, medications such as hydralazine, quinidine, phenytoin, and amoxicillin, family history- antiphospholipid syndrome is common in patients with a family history of antiphospholipid syndrome.
The most common risk factors of antiphospholipid syndrome risk factors are history of autoimmune diseases like SLE, sjogren's syndrome, infections- cytomegalovirus, human immunodeficiency virus, parvovirus B-19, hepatitis C virus, lyme's disease, syphilis, E.coli, leptospirosis, medications such as hydralazine, quinidine, phenytoin, and amoxicillin, family history- antiphospholipid syndrome is common in patients with a family history of antiphospholipid syndrome.
==Risk Factors==
==Risk Factors==
The risk factors associated with antiphospholipid syndrome(APS) are as follows:<ref name="pmid20822807">{{cite journal |vauthors=Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA |title=Antiphospholipid syndrome |journal=Lancet |volume=376 |issue=9751 |pages=1498–509 |date=October 2010 |pmid=20822807 |doi=10.1016/S0140-6736(10)60709-X |url=}}</ref><ref name="pmid22510982">{{cite journal |vauthors=Willis R, Harris EN, Pierangeli SS |title=Pathogenesis of the antiphospholipid syndrome |journal=Semin. Thromb. Hemost. |volume=38 |issue=4 |pages=305–21 |date=June 2012 |pmid=22510982 |doi=10.1055/s-0032-1311827 |url=}}</ref><ref name="pmid24129681">{{cite journal |vauthors=Gris JC, Brenner B |title=Antiphospholipid antibodies: neuropsychiatric presentations |journal=Semin. Thromb. Hemost. |volume=39 |issue=8 |pages=935–42 |date=November 2013 |pmid=24129681 |doi=10.1055/s-0033-1357488 |url=}}</ref><ref name="pmid25228741">{{cite journal |vauthors=Koike T |title=My contribution, my dream - a look at the future of APS |journal=Lupus |volume=23 |issue=12 |pages=1332–4 |date=October 2014 |pmid=25228741 |doi=10.1177/0961203314534306 |url=}}</ref><ref name="pmid24642799">{{cite journal |vauthors=Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D |title=Renal involvement in antiphospholipid syndrome |journal=Nat Rev Nephrol |volume=10 |issue=5 |pages=279–89 |date=May 2014 |pmid=24642799 |doi=10.1038/nrneph.2014.38 |url=}}</ref>
The risk factors associated with antiphospholipid syndrome(APS) are as follows:<ref name="pmid20822807">{{cite journal |vauthors=Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA |title=Antiphospholipid syndrome |journal=Lancet |volume=376 |issue=9751 |pages=1498–509 |date=October 2010 |pmid=20822807 |doi=10.1016/S0140-6736(10)60709-X |url=}}</ref><ref name="pmid22510982">{{cite journal |vauthors=Willis R, Harris EN, Pierangeli SS |title=Pathogenesis of the antiphospholipid syndrome |journal=Semin. Thromb. Hemost. |volume=38 |issue=4 |pages=305–21 |date=June 2012 |pmid=22510982 |doi=10.1055/s-0032-1311827 |url=}}</ref><ref name="pmid24129681">{{cite journal |vauthors=Gris JC, Brenner B |title=Antiphospholipid antibodies: neuropsychiatric presentations |journal=Semin. Thromb. Hemost. |volume=39 |issue=8 |pages=935–42 |date=November 2013 |pmid=24129681 |doi=10.1055/s-0033-1357488 |url=}}</ref><ref name="pmid25228741">{{cite journal |vauthors=Koike T |title=My contribution, my dream - a look at the future of APS |journal=Lupus |volume=23 |issue=12 |pages=1332–4 |date=October 2014 |pmid=25228741 |doi=10.1177/0961203314534306 |url=}}</ref><ref name="pmid24642799">{{cite journal |vauthors=Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D |title=Renal involvement in antiphospholipid syndrome |journal=Nat Rev Nephrol |volume=10 |issue=5 |pages=279–89 |date=May 2014 |pmid=24642799 |doi=10.1038/nrneph.2014.38 |url=}}</ref>

Revision as of 15:50, 24 April 2018

Antiphospholipid syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Antiphospholipid syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Antiphospholipid syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Antiphospholipid syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Antiphospholipid syndrome risk factors

CDC on Antiphospholipid syndrome risk factors

Antiphospholipid syndrome risk factors in the news

Blogs on Antiphospholipid syndrome risk factors

Directions to Hospitals Treating Antiphospholipid syndrome

Risk calculators and risk factors for Antiphospholipid syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]

Overview

The most common risk factors of antiphospholipid syndrome risk factors are history of autoimmune diseases like SLE, sjogren's syndrome, infections- cytomegalovirus, human immunodeficiency virus, parvovirus B-19, hepatitis C virus, lyme's disease, syphilis, E.coli, leptospirosis, medications such as hydralazine, quinidine, phenytoin, and amoxicillin, family history- antiphospholipid syndrome is common in patients with a family history of antiphospholipid syndrome.

Risk Factors

The risk factors associated with antiphospholipid syndrome(APS) are as follows:[1][2][3][4][5]

Common risk factors

  • History of autoimmune disease:
    • SLE
    • Sjogren's syndrome
  • Infections:
    • Cytomegalovirus
    • Human Immunodeficiency Virus
    • Parvovirus B-19
    • Hepatitis C Virus
    • Lymes
    • Syphilis
    • E.coli
    • Leptospirosis.
  • Drugs:
    • Hydralazine
    • Quinidine
    • Phenytoin
    • Amoxicillin
  • Family history: Antiphospholipid syndrome is common in patients with a family history of antiphospholipid syndrome.

Less common risk factors:

  • Pregnancy
  • Obesity
  • Hypertension
  • Sedentary lifestyle
  • Recent surgery
  • Tobacco Smoking
  • Oral contraceptives
  • Estrogen therapy
  • Hyperlipidemias
  • Cancer

References

  1. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (October 2010). "Antiphospholipid syndrome". Lancet. 376 (9751): 1498–509. doi:10.1016/S0140-6736(10)60709-X. PMID 20822807.
  2. Willis R, Harris EN, Pierangeli SS (June 2012). "Pathogenesis of the antiphospholipid syndrome". Semin. Thromb. Hemost. 38 (4): 305–21. doi:10.1055/s-0032-1311827. PMID 22510982.
  3. Gris JC, Brenner B (November 2013). "Antiphospholipid antibodies: neuropsychiatric presentations". Semin. Thromb. Hemost. 39 (8): 935–42. doi:10.1055/s-0033-1357488. PMID 24129681.
  4. Koike T (October 2014). "My contribution, my dream - a look at the future of APS". Lupus. 23 (12): 1332–4. doi:10.1177/0961203314534306. PMID 25228741.
  5. Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D (May 2014). "Renal involvement in antiphospholipid syndrome". Nat Rev Nephrol. 10 (5): 279–89. doi:10.1038/nrneph.2014.38. PMID 24642799.